Detalles de la búsqueda
1.
Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma.
Oncologist;
28(1): 59-71, 2023 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35881028
2.
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial.
J Thorac Oncol;
19(6): 941-953, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159809
3.
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
J Clin Oncol;
41(12): 2166-2180, 2023 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36473143
4.
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
J Immunother Cancer;
11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848259
5.
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.
Cancer;
118(24): 6152-61, 2012 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22692704
6.
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
Lancet Oncol;
12(12): 1125-33, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22019520
7.
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial.
Eur Urol;
82(3): 283-292, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35210132
8.
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.
Int J Cancer;
127(9): 2209-21, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20473913
9.
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer.
Oncotarget;
11(33): 3105-3117, 2020 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32913555
10.
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
Lancet;
370(9605): 2103-11, 2007 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-18156031
11.
Capecitabine as adjuvant treatment for stage III colon cancer.
N Engl J Med;
352(26): 2696-704, 2005 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-15987918
12.
[Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group]. / Drobnokomórkowy rak pluca - zalecenia diagnostyczno-terapeutyczne Polskiej Grupy Raka Pluca.
Pneumonol Alergol Pol;
75(1): 88-94, 2007.
Artículo
en Polaco
| MEDLINE | ID: mdl-17541917
13.
Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer.
Cancer Chemother Pharmacol;
63(5): 937-43, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18751706
14.
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.
J Clin Oncol;
27(5): 663-71, 2009 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19114683
15.
Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.
J Clin Oncol;
26(28): 4544-50, 2008 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18824706
16.
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
J Clin Oncol;
25(16): 2171-7, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17538161
17.
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
J Clin Oncol;
24(9): 1428-34, 2006 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16549837
Resultados
1 -
17
de 17
1
Próxima >
>>